Latest News and Press Releases

CHICAGO, May 30, 2019 (GLOBE NEWSWIRE) -- Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today an...

CHICAGO, May 30, 2019 (GLOBE NEWSWIRE) -- Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today an...

ALEXANDRIA, Va. and CHICAGO, Jan. 10, 2019 (GLOBE NEWSWIRE) -- The American Society of Clinical Oncology, Inc. (ASCO) and Tempus announced today an agreement to support research sites participating...

CHICAGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, today announced the...

CHICAGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today it...

Having met rigorous qualifications, Tempus joins a select group of commercial and academic laboratories designated to cast a wider net for patients to enter the trial CHICAGO, Aug. 02, 2018 (GLOBE...

CHICAGO, May 08, 2018 (GLOBE NEWSWIRE) -- Tempus today announced a new initiative that will allow physicians to sequence a second patient sample without additional charge, removing a barrier that...

CHICAGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data,...

CHICAGO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data,...

CHICAGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data,...